MarketInOut Stock Screener Log In | Sign Up
 

Artivion Inc

NYSE • Healthcare • Medical Devices • Quote as of 10/13/2026 16:00
Artivion Inc stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeNYSE
Market Capitalization1,036.56 mln
Float46.16 mln
Earnings Date10/29/2026

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-2.63
Likely reliable

Relative Strength

24 / 100
Significantly lagging

Debt / Equity

0.92
Moderate leverage

Pre-Tax Margin

0%
Break-even

ROE

-0.72
Negative

Business Description

Artivion is a global medical company that develops and supplies a broad range of products designed to treat heart and vascular conditions, including artificial heart valves, stent graft systems, surgical sealants, and preserved human tissue. The company also offers specialized services such as tissue preservation and proprietary coating technologies used by surgeons during complex cardiovascular procedures. Founded in 1984 and based in Kennesaw, Georgia, Artivion sells its products directly to hospitals and healthcare facilities through its own sales team. Previously known as CryoLife, the company rebranded under its current name in January 2022.

Key Fundamentals

EPS-0.07
ROE-0.72
RPS9.85
ROIC-2.75
ROA-0.35
Interest Cover1.29
EBITDA, mln51.06
EV / EBITDA28.24
EV / EBIT54.40
Revenue, mln471
EV / Revenue3.06

Quote Details

Last 21.36
Change -0.43 (-1.97%)
Open 21.83
Volume 663,263
Turnover 14,167,298
Average Volume 610,559

Financial Ratios

Pre-Tax Profit Margin0
Leverage Ratio2.41
Current Ratio2.97
Price / Book2.50
Price / Cash Flow25.83
Debt / Equity0.92
Price / Sales2.37
PEG Ratio7.39

Financial Strength

Altman Z-Score1.74
Piotroski F-Score 5 / 9
Beneish M-Score-2.63
Price to Intrinsic Value3.48
Price to Lynch Fair Value6.10
Short Ratio5.17
Short % of Float8.09

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -2.2% 37 / 100   
1 Month -14.46% 18 / 100   
2 Months -9.41% 31 / 100   
6 Months -43.72% 12 / 100   
1 Year -46.87% 18 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us